Cannabis

CANNTAB RECEIVES INITIAL INDICATION OF PATENTABILITY FOR IMMEDIATE RELEASE CANNABIDIOL FORMULATION

TORONTO, July 31st, 2019/ – Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) (the “Company” or “Canntab“), the leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic application, is pleased to announce that it […]